Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1951 - 1975 of 2342 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ▲ ChEBI ID Exact Mass Formula
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA03
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/20:0)
44261942 1079.733169 C56H105NO18
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA04
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/22:0)
44261943 1107.764469 C58H109NO18
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA05
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/24:0)
44261944 1135.795769 C60H113NO18
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA06
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/26:0)
44261945 1163.827069 C62H117NO18
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA07
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261946 1133.780119 C60H111NO18
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA08
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261947 1161.811419 C62H115NO18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA01
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/16:0)
44261948 1064.697118 C54H100N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA02
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/18:0)
44261949 1092.728418 C56H104N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA03
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/20:0)
44261950 1120.759718 C58H108N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA04
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/22:0)
44261951 1148.791018 C60H112N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA05
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/24:0)
44261952 1176.822318 C62H116N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA06
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/26:0)
44261953 1204.853618 C64H120N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA07
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261954 1174.806668 C62H114N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA08
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261955 1202.837968 C64H118N2O18
Gal- (Gala series) LMSP0509AA01
  • Galalpha1-4Galbeta-Cer(d18:1/16:0)
44261956 861.617744 C46H87NO13
Gal- (Gala series) LMSP0509AA02
  • Galalpha1-4Galbeta-Cer(d18:1/18:0)
44261957 889.649044 C48H91NO13
Gal- (Gala series) LMSP0509AA03
  • Galalpha1-4Galbeta-Cer(d18:1/20:0)
44261958 917.680344 C50H95NO13
Gal- (Gala series) LMSP0509AA04
  • Galalpha1-4Galbeta-Cer(d18:1/22:0)
44261959 945.711644 C52H99NO13
Gal- (Gala series) LMSP0509AA05
  • Galalpha1-4Galbeta-Cer(d18:1/24:0)
44261960 973.742944 C54H103NO13
Gal- (Gala series) LMSP0509AA06
  • Galalpha1-4Galbeta-Cer(d18:1/26:0)
44261961 1001.774244 C56H107NO13
Gal- (Gala series) LMSP0509AA07
  • Galalpha1-4Galbeta-Cer(d18:1/24:1(15Z))
44261962 971.727294 C54H101NO13
Gal- (Gala series) LMSP0509AA08
  • Galalpha1-4Galbeta-Cer(d18:1/26:1(17Z))
44261963 999.758594 C56H105NO13
Simple Glc series LMSP05010109
  • Cortenuamide C
  • N-(2R-hydroxy-docosanoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine
45272231 811.653734 C47H89NO9
Simple Glc series LMSP05010031
  • 1-beta-glucosyl-sphing-4-enine
  • Glucosyl sphingosine
C03108 5280570 71981 461.335254 C24H47NO7
Simple Glc series LMSP0501AB06
  • LacCer(d18:1/22:0)
  • N-(docosanoyl)-1-beta-lactosyl-sphing-4-enine
52921641 84762 945.711644 C52H99NO13

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024